01
Clarify the finding
Symptoms, examination, possible diagnosis and disease activity precede care.
Medical Skin Care · Physician-Led Assessment · Istanbul
Medical Skin Care
Barrier support, acne care, pigment concerns, redness and scar or texture questions retain separate diagnoses, methods and risks. They are not presented as one skin-renewal package.
Cosmetic care is separated from medical assessment, disease treatment, peels, injections and device-based procedures.
Physician-Led Orientation
Four levels before method selection
A reasoned sequence begins with the clinical question.
Online review can organise the question. Final suitability follows from in-person examination, the exact product or device and an individual risk–benefit assessment.
02
Review personal risk
Skin type, barrier, pigment, scar tendency, medicines and previous procedures matter.
03
Identify the exact option
Product category, formulation, procedure and target remain distinct.
04
Set follow-up
Expected response, complication signs and referral routes are agreed.
Medical Skin Care · 01–03
Barrier and procedures
Supportive care and procedures retain different roles.
Barrier support, chemical peel and the existing medical microneedling canonical are linked without merging their clinical tasks.
01Skin care
Clinical Skin Care and Barrier Support
Barrier function, irritants and product roles after the clinical finding is clarified.
Decision boundaryOne existing canonical route; diagnosis, suitability and outcome remain individual.
Open Clinical Skin Care and Barrier Support02Procedure
Chemical Peel
Peel depth, formulation, pigment risk and monitoring kept explicit.
Decision boundaryOne existing canonical route; diagnosis, suitability and outcome remain individual.
Open Chemical Peel03Existing method
Medical Microneedling
Existing EN-I5 canonical; linked once without recreating its content.
Decision boundaryOne existing canonical route; diagnosis, suitability and outcome remain individual.
Open Medical MicroneedlingMedical Skin Care · 04–05
Acne and scarring
Active disease and established scars are assessed separately.
Acne care does not replace medical treatment; scar morphology determines later method discussion.
01Acne care
Medical Skin Care for Acne
Supportive care separated from diagnosis and prescription treatment.
Decision boundaryOne existing canonical route; diagnosis, suitability and outcome remain individual.
Open Medical Skin Care for Acne02Scar assessment
Acne Scars and Skin Texture
Scar morphology and active acne assessed before method selection.
Decision boundaryOne existing canonical route; diagnosis, suitability and outcome remain individual.
Open Acne Scars and Skin Texture03Pigment assessment
Melasma and Pigmentation Disorders
Diagnosis and malignancy exclusion before pigment-directed care.
Decision boundaryOne existing canonical route; diagnosis, suitability and outcome remain individual.
Open Melasma and Pigmentation DisordersMedical Skin Care · 06–07
Pigment, redness and sensitivity
Diagnosis precedes aesthetic care.
Melasma, suspicious lesions, rosacea, dermatitis and infection retain separate boundaries.
01Redness and sensitivity
Rosacea and Sensitive Skin
Rosacea, sensitivity, dermatitis, acne and infection kept distinct.
Decision boundaryOne existing canonical route; diagnosis, suitability and outcome remain individual.
Open Rosacea and Sensitive SkinQuality and Safety Framework
Four binding principles
Premium care means clearer selection, boundaries and follow-up.
Advertising language and package logic are replaced by product traceability, anatomy, proportionate alternatives and documented review.
01
Diagnosis before care
Do not reduce disease or a suspicious lesion to a cosmetic concern.
02
Identity before claim
Name the product or procedure and its exact role.
03
Risk before repetition
Pigment, scar, infection and disease-activity risks shape follow-up.
04
No treatment remains valid
Care, oral treatment, referral, observation or no intervention may be more proportionate.
Bağdat Caddesi · Istanbul
International patient pathway
Travel, examination and follow-up form one medical process.
The in-person appointment remains the decision point. Product records, early safety, return travel and local medical access are considered before treatment.
- 01Before travel
Organise the question
History and existing records prepare discussion without confirming treatment.
- 02In Istanbul
Assess in person
Diagnosis, activity, barrier, risk and alternatives are reviewed.
- 03Treatment day
Keep traceability
Products, procedures, sites and observations are recorded.
- 04After return
Arrange escalation
Warning signs and local medical access are agreed before departure.
The Doctor Aslan Approach
Clinical finding before skin-care category
Different skin questions keep different care pathways.
Doctor Aslan separates diagnosis, disease activity, barrier status, methods and referral needs before planning care.
Assess first
Clarify the skin finding and disease activity.
Verify identity
Keep care, products, peels and devices distinct.
Limit the claim
No renewal, clearing or universal suitability promise.
Accept no treatment
Withholding treatment remains a valid decision.
Medical responsibility: Dr İsmail AslanMedical review: 24 August 2026General patient information about Medical Skin Care; no personal protocol or outcome guarantee
Frequently Asked Questions
Short and clear
Questions commonly asked before a decision.
These answers provide general orientation and do not replace personal diagnosis or treatment planning.
01What is Medical Skin Care?+
Medical Skin Care is described on this page as one defined clinical route. Its role, limits and possible alternatives are considered together rather than treating the method name as a personal recommendation.
02Who may be assessed for Medical Skin Care?+
Suitability depends on the medical question, history, examination, the exact product or device where relevant, realistic aims and an individual benefit–risk assessment.
03What remains undecided after an online review?+
Diagnosis, definitive suitability, the treatment protocol, product, dose or device settings, expected response and the option not to proceed remain subject to personal medical assessment.
04How are treatment and follow-up in Istanbul planned?+
The in-person examination remains the decision point. Expected early reactions, warning signs, the direct contact route, return travel and access to appropriate local medical care are discussed before treatment.
Next Step
Define the finding · separate the methods · plan review